A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome
Stephen J Eyler1, Nicole C Meyer, Yuzhou Zhang
1Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, 5270 CBRB Building, Iowa City, IA, 52242, USA.
Background:
Mutations in complement factor H (CFH) are associated with complement dysregulation and the development of an aggressive form of atypical hemolytic uremic syndrome (aHUS) that progresses to end-stage renal disease (ESRD) and in most patients has a high rate of recurrence following transplantation. Sequence analysis of CFH and its downstream complement factor H-related genes (CFHR1-5) reveals several macrohomologous blocks caused by large genomic duplications. This high degree of sequence identity renders this area susceptible to nonallelic homologous recombination (NAHR) events, resulting in large-scale deletions, duplications, and the generation of hybrid CFH genes.
Case-Diagnosis:
Here, we report the finding of a novel CFHR1/CFH hybrid gene created by a de novo NAHR event in a 14-year-old girl with aHUS. The resulting fusion protein contains the first three short consensus repeats (SCRs) of CFHR1 and the terminal two SCRs of CFH.
Conclusions:
This finding demonstrates a novel pathogenic mechanism for the development of aHUS. Additionally, since standard Sanger sequencing is unable to detect such rearrangements, all aHUS patients should receive comprehensive genetic screening that includes analysis of copy number variation in order to identify patients with poor clinical prognoses.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Huntington Disease l: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
FISH - Fluorescent In-situ Hybridization
Hypersensitivity Reactions: Cytolytic Reactions


